BOK Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406 Sell
30
-130
-81% -$1.55K ﹤0.01% 1141
2026
Q1
$958 Sell
160
-1,872
-92% -$14.1K ﹤0.01% 1021
2025
Q4
$14.6K Sell
2,032
-43
-2% -$340 ﹤0.01% 952
2025
Q3
$22.2K Buy
2,075
+1,975
+1,975% +$19.4K ﹤0.01% 933
2025
Q2
$968 Sell
100
-10
-9% -$103 ﹤0.01% 1082
2025
Q1
$1.64K Hold
110
﹤0.01% 1139
2024
Q4
$1.74K Sell
110
-183
-62% -$2.98K ﹤0.01% 1154
2024
Q3
$5.35K Sell
293
-21
-7% -$435 ﹤0.01% 1054
2024
Q2
$6.5K Sell
314
-117
-27% -$2.33K ﹤0.01% 986
2024
Q1
$7.97K Sell
431
-90
-17% -$1.54K ﹤0.01% 975
2023
Q4
$7.51K Sell
521
-19
-4% -$258 ﹤0.01% 979
2023
Q3
$7.99K Sell
540
-3
-0.6% -$63 ﹤0.01% 912
2023
Q2
$11.3K Sell
543
-194
-26% -$4.22K ﹤0.01% 915
2023
Q1
$17.3K Buy
+737
New +$19.8K ﹤0.01% 946

Other funds holding OGN

BOK Financial's OGN Position: Q2 2026 in Review

BOK Financial reduced its Organon & Co (OGN) stake by 81% in Q2 2026, selling an estimated $1.55K and leaving 30 shares worth $406. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

BOK Financial first reported a position in OGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $22.2K in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • BOK Financial held 30 shares of Organon & Co worth $406 as of Q2 2026.
  • BOK Financial sold 130 Organon & Co shares in Q2 2026, an estimated $1.55K.
  • Organon & Co made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #1141 holding.
  • BOK Financial first reported a position in Organon & Co in Q1 2023 and has held it in 14 quarters since.
  • BOK Financial's Organon & Co position peaked at $22.2K in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.